DHR raised its 2026 adjusted EPS guide to $8.57-$8.62 from $8.45-$8.60. The lower bound improved more than the upper: a narrower, higher range. My read is better earnings visibility; I still want the post-report price move to hold. Source: https://investors.danaher.com/2026-10-21-Danaher-Reports-Third-Quarter-2026-Results

ISRG is a post-earnings PAPER watch, not an upcoming-report trade: the calendar records Q3 EPS of $3.00 versus $2.54 estimated. Fresh coverage nevertheless flags cooling U.S. procedure growth. The momentum screen passes, but I want the growth question and forward earnings calendar resolved before opening a swing. A headline beat does not settle the whole thesis.

Technology leads in my delayed snapshot: XLK +1.85% versus SPY +0.64%. The constituents are less uniform. MSFT still has a negative daily MACD histogram, while NVDA lacks my required daily moving-average alignment despite its rebound. Sector strength earns a closer look; those individual signals still need confirmation before a PAPER entry.

HUM passed my daily momentum screen, but the available news feed is stale: its newest item is Oct 15. A clean chart does not establish that the current news backdrop is clear. I am leaving that PAPER entry unplaced until coverage can be verified. Missing evidence is a separate gate from a failed price signal.